| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/12/2004 | EP1052984B1 Antibacterial agents |
| 05/12/2004 | EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides |
| 05/12/2004 | CN1496407A Flavonoid compound and process for producing the same |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496270A Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 05/12/2004 | CN1496267A Preventives for microbial infections |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495181A Method for preparing cyclic oxazolidone containing sulfur and fluorine |
| 05/12/2004 | CN1494922A Purification method of dermatonecrotoxin and anatoxin produced by Bordetella |
| 05/12/2004 | CN1494912A Method for curing diseases related to cell factor |
| 05/12/2004 | CN1494911A Slowly-reteased preparation of erythromycin derivative |
| 05/12/2004 | CN1494902A Application of high-solubility berberine in preparation of medicine. |
| 05/12/2004 | CN1494898A Valacycloguanosine tablet containing colloid silica |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/12/2004 | CN1149281C Kinase activating dependent cyclin protein kinases, and their uses |
| 05/12/2004 | CN1149223C Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/12/2004 | CN1149220C Bromotiacumicin cpmpounds |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149192C Process for preparing protected 4-aminomethyl-pyrrolidin-3-one |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149096C Medicine for treating drug-fast tuberculosis |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/12/2004 | CN1149075C Enteric coated pharmaceutical compsn, and method of mfg. |
| 05/12/2004 | CN1149018C Method and equipment for destructive distillation of haw kernel to extract juice |
| 05/11/2004 | US6734307 Use against multiply resistant gram positive pathogens; have a diazine moiety attached to the phenyloxazolidinone which is further substituted by heterocyclic, aryl, substituted aryl, heteroaroamatic ring |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734212 Methods and compositions for treating or preventing bacterial infection |
| 05/11/2004 | US6734200 Antibiotic compounds containing a substituted oxazolidinone ring; activity against gram-positive pathogens |
| 05/11/2004 | US6734191 Chemokine receptor binding heterocyclic compounds |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734170 Cellular uptake of bioactive agents |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734161 Peptide nucleic acids having antibacterial activity |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |
| 05/11/2004 | US6733754 Adjuvants for use in vaccines |
| 05/11/2004 | US6733751 Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/11/2004 | CA2074188C Vector with multiple tat activation response elements affecting gene expression |
| 05/11/2004 | CA2062341C Use of hydrophilic penetrating agents in dermatological compositions for the treatment of onychomycosis, and corresponding compositions |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037818A1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 05/06/2004 | WO2004037290A1 Sustained release composition for oral administration of drugs |
| 05/06/2004 | WO2004037272A1 Dengue virus infection inhibitor |
| 05/06/2004 | WO2004037263A1 Pharmaceutical compositions of ganciclovir |
| 05/06/2004 | WO2004037237A1 Pharmaceutical compositions comprising flavonoids and menthol |
| 05/06/2004 | WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | WO2004037163A2 STERICALLY-AWKWARD β-LACTAMASE INHIBITORS |
| 05/06/2004 | WO2004037161A2 Cyclic prodrugs of pmea one of its analogues |
| 05/06/2004 | WO2004022041A3 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 05/06/2004 | WO2004019976A3 Pharmaceutical liposomal compositions containing n. meningitidis derived polypeptides or polynucleotides |
| 05/06/2004 | WO2004018463A3 Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| 05/06/2004 | WO2004018451A8 Pyridazinone-derivatives as pde4 inhibitors |
| 05/06/2004 | WO2004002433A8 Synergistic interaction of abacavir and alovudine |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003100036A3 Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase |
| 05/06/2004 | WO2003082853A8 New compounds |
| 05/06/2004 | WO2003051365A9 Use of compounds of the benzamide family as immunosuppressant |
| 05/06/2004 | WO2003051304A3 Bioadhesive drug delivery system with enhanced gastric retention |
| 05/06/2004 | WO2003048186B1 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 05/06/2004 | WO2003046008A9 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| 05/06/2004 | WO2003022298A3 Use of a protein of the crmp family for treating diseases related to the immune system |
| 05/06/2004 | WO2003020219B1 Aerosolized decongestants for the treatment of sinusitis |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | WO2003004467A3 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 05/06/2004 | WO2002022150A3 Medicament containing activated antithrombin iii |
| 05/06/2004 | US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain. |
| 05/06/2004 | US20040087796 Substituted carbazoles as inhibitors of spla2 |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087654 Nitric oxide synthase inhibitor phosphate salt |
| 05/06/2004 | US20040087653 Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087628 Enzyme inhibitors; antiarthritic agents; psoriasis; viricides; bactericides |
| 05/06/2004 | US20040087624 Analgesics; antiinflammatory agents; immunology; bone disorders; neurodegradation diseases |
| 05/06/2004 | US20040087619 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
| 05/06/2004 | US20040087602 Topical viricide; photostabilizer for inorganic oxide pigment; 2-bromovinyl deoxyuridine mixtures |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087557 Treating muscle wasting with selective androgen receptor modulators |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087510 Cardiovascular diseases and disorders; sustained delivery of nitric oxide |
| 05/06/2004 | US20040087002 Using attenuated viral sequence to develop vaccines to prevent porcine reproductive and respiratory syndrome in swine; immunotherapy |
| 05/06/2004 | US20040086988 Enzyme catalyst; polypeptides; crystal structure |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |